Results of Entecavir treatment in patients with chronic hepatitis B

Journal Title: Journal of Microbiology and Infectious Diseases - Year 2013, Vol 3, Issue 4

Abstract

Objective: This study was designed to determine the efficacy and safety of Entecavir (ETV) after 96 weeks treatment in patients with chronic viral hepatitis B (CHB). Methods: Thirty-eight patients were included into the study. The criteria for starting ETV treatment were as follows: elevated ALT levels >upper limit of normal (ULN) two times, with HBV-DNA levels ≥5 log10 copies/ml (≥20000 IU/mL), in HBe Ag positive patients, ≥4log10 copies/ml (≥2000IU/mL) in HBe Ag negative patients and liver damage was confirmed by histopathology (Knodell HAI ≥4 or fibrosis ≥1). Patients were followed up every 12 weeks by virological and biochemical tests. Results: Twenty-four of 38 patients (63.2%) were male. Mean age of patients were 38.6 years, 14 of them were HBeAg positive (36.8%). At baseline, median ALT level was detected as 106.7 IU/ml, median HBV DNA levels were 4.8 x 107 copy/ml, and mean Knodell HAI score was nine. Eleven of 14 HBe Ag positive patients (78.6%) were treatment-naïve. No resistance mutation was determined during treatment. Biochemical responses (BR) at 48th and 96th week were 100% and virologic response (VR) were 57.1%, and 50%, respectively. Serological response (SR) at 48th and 96th weeks were 35.7% and 42.8% respectively. Fifteen (62.5%) of 24 HBe Ag negative patients were treatment-naïve; two patients were detected to have lamivudine resistance mutation. At 48th and 96th week, BR was 95.8%, and 100%, respectively; and VR were 83.3% both. Conclusion: In our study, virologic response was significantly high after two years of therapy with Entecavir in HBe Ag negative patients. J Microbiol Infect Dis 2013;3(4): 176-180 Key words: Chronic hepatitis B, Entecavir, therapy

Authors and Affiliations

Şükran Köse, Melda Türken, Bengü Tatar

Keywords

Related Articles

Evaluation of Diagnostic Tests for Visceral Leishmaniasis in Iran: A Meta-Analysis

Objective: There exist various diagnostic tests to detect visceral leishmaniasis, but the most efficient ones have not been demonstrated yet. Herein, we evaluated the accuracy of these diagnostic tests in Iran. Methodolo...

Persistent colonization of Helicobacter pylori in human gut induces gastroduodenal diseases

Helicobacter pylori are gut bacteria colonize in the epithelial cell lining of the stomach and persist there for long du­ration. Around two-thirds of the world’s populations are infected with H. pylori and cause more th...

Yoğun bakım ünitelerinde yatan yaşlı hastalarda görülen nozokomiyal infeksiyonlar ve risk faktörleri

65 yaş üzerindeki hastalarda nozokomiyal infeksiyon sıklığı her geçen gün artmaktadır ve ilerlemiş hasta yaşı ile nozokomiyal infeksiyon arasında belirgin bir ilişki bulunmaktadır. Bu hastalarda konak savunmasının azalma...

High imported malaria incidence at a Moroccon military hospital

Objective:To evaluate the importance of imported malaria at the Moulay Ismail Military Hospital of Meknes, we have led a descriptive study of the epidemiological, clinical, biological and evolutionary characteristics of...

Yoğun Bakım Ünitesinde Gelişen Enfeksiyonlar ve Mortalite ile İlişkisi: Prospektif Üçüncü Basamak Bir Türk Hastanesindeki Çalışma

Amaç:Biz bu çalışmada, yoğun bakım ünitesinde (YBÜ) gelişen enfeksiyonların epidemiyolojik özelliklerini ve mortalite ile ilişkili risk faktörlerini araştırmayı hedefledik. Yöntemler:Dokuz aylık bir periyotta Ankara Num...

Download PDF file
  • EP ID EP162283
  • DOI 10.5799/ahinjs.02.2013.04.0104
  • Views 81
  • Downloads 0

How To Cite

Şükran Köse, Melda Türken, Bengü Tatar (2013). Results of Entecavir treatment in patients with chronic hepatitis B. Journal of Microbiology and Infectious Diseases, 3(4), 176-180. https://europub.co.uk/articles/-A-162283